- Revenue Cycle Management
- COVID-19
- Reimbursement
- Diabetes Awareness Month
- Risk Management
- Patient Retention
- Staffing
- Medical Economics® 100th Anniversary
- Coding and documentation
- Business of Endocrinology
- Telehealth
- Physicians Financial News
- Cybersecurity
- Cardiovascular Clinical Consult
- Locum Tenens, brought to you by LocumLife®
- Weight Management
- Business of Women's Health
- Practice Efficiency
- Finance and Wealth
- EHRs
- Remote Patient Monitoring
- Sponsored Webinars
- Medical Technology
- Billing and collections
- Acute Pain Management
- Exclusive Content
- Value-based Care
- Business of Pediatrics
- Concierge Medicine 2.0 by Castle Connolly Private Health Partners
- Practice Growth
- Concierge Medicine
- Business of Cardiology
- Implementing the Topcon Ocular Telehealth Platform
- Malpractice
- Influenza
- Sexual Health
- Chronic Conditions
- Technology
- Legal and Policy
- Money
- Opinion
- Vaccines
- Practice Management
- Patient Relations
- Careers
Rite Aid files for bankruptcy; Elf Bar finds a way around ban; New mouse study could combat multiple sclerosis - Morning Medical Update
The top news stories in primary care today.
doctor morning desk © Alena Kryazheva - stock.adobe.com
Pharmacy chain Rite Aid filed for bankruptcy this weekend, after lawsuits alleging the over prescription of opioids drained their finances. Total debt is listed at $8.6 billion as of June 3. Total assets are listed at $7.6 billion. Underperforming locations have already begun to close.
Elf Bar finds a way around ban
After being banned by the Food and Drug Administration, Elf Bars are back under a new name – EBCreate. The top-selling disposable electronic cigarettes generated $271 million in revenue last year. “The FDA has confiscated more heads of romaine lettuce than it has illegal e-cigarettes in the last five years,” Desmond Jenson, an attorney at the Public Health Law Center said in a statement.
New mouse study could combat multiple sclerosis
Researchers studying multiple sclerosis in mice have identified a protein that could reshape MS treatments. According to the study the protein ‘boots the aggressive migration of immune cells into the central nervous system, leading to MS’. When scientists blocked the protein, it prevented damage and improved symptoms in mice.
